Mary Hamby

Mary Hamby

Company: Cognition Therapeutics

Job title: Vice President of Research


Targeting the Sigma-2 Receptor (S2R) for Dry AMD with an Oral Small Molecule Approach: Preclinical & Clinical Biomarker Support 1:00 pm

Background on target and rationale for dry AMD Preclinical data support a unique mechanism of action to restore RPE homeostatic function Proteomic biomarker evidence that the S2R modulator CT1812 can alter dry AMD relevant protein and pathways in an aged populationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.